Permissive Weight Bearing in Displaced Intra-articular Calcaneal Fractures
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Feb 7, 2023
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the best way to help people recover after a specific type of foot fracture called a displaced intra-articular calcaneal fracture, which affects the heel bone. The study will compare two approaches to weight-bearing after surgery: one where patients can put some weight on their foot (permissive weight bearing) and another where they need to keep their weight off the foot for a longer period (restricted weight bearing). Researchers want to see which method leads to better recovery, fewer complications, and improved quality of life.
To participate in this trial, you need to be between 18 and 67 years old and have had surgery for a specific type of heel fracture within the last six weeks. You should be able to understand the instructions and questionnaires related to the study. However, if you have certain conditions like severe arthritis, other serious health issues, or previous amputations, you may not be eligible. If you choose to take part, you can expect to follow a rehabilitation program and help researchers learn more about the best ways to recover from this type of injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Surgically treated trauma patients with isolated unilateral DIACFs, less than 6 weeks after trauma, Sanders type II-IV (14)
- • Age between 18 and 67 years old (labor force)
- • Being able to understand the questionnaires and measurement instructions
- • Indication for open/closed reduction and internal fixation
- • Written Informed Consent
- Exclusion Criteria:
- • Acute or existing amputation (upper limb, lower limb, feet)
- • Open calcaneal fractures (excluding medial wound without compromising surgical approach)
- • Bilateral fractures of the lower extremities
- • Unable to comply to the PWB protocol due to pre-existing conditions of the arms and legs (e.g. unable to use crotches due to hemiparalysis)
- • Severe non-fracture related comorbidity of the lower extremity
- • Pre-existent immobility (loss of muscle function of one or both legs)
- • Dependent in activities of daily living (e.g. due to dementia, Alzheimer, New York Heart Association class IV angina, heart failure or oxygen-dependent chronic obstructive pulmonary disease)
- • Rheumatoid arthritis of the lower extremities
- • Severe psychiatric comorbidities that lead to inability to comply with the treatment protocol
- • Pathologic fractures (metastasis, secondary osteoporosis)
- • Peripheral neuropathy and/or diabetes
- • Alcohol- or drug abuse preventing adequate follow-up
- • Primary indication for arthrodesis subtalar joint
- • Two or more fractures of the upper and/or lower extremities
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arnhem, , Netherlands
Breda, , Netherlands
Gouda, , Netherlands
Eindhoven, , Netherlands
Nijmegen, , Netherlands
Rotterdam, , Netherlands
Maastricht, , Netherlands
Den Haag, , Netherlands
Amsterdam, , Netherlands
Sittard, , Netherlands
Tilburg, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials